These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12244082)

  • 1. Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study.
    Khan NL; Brooks DJ; Pavese N; Sweeney MG; Wood NW; Lees AJ; Piccini P
    Brain; 2002 Oct; 125(Pt 10):2248-56. PubMed ID: 12244082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nigrostriatal dysfunction in homozygous and heterozygous parkin gene carriers: an 18F-dopa PET progression study.
    Pavese N; Khan NL; Scherfler C; Cohen L; Brooks DJ; Wood NW; Bhatia KP; Quinn NP; Lees AJ; Piccini P
    Mov Disord; 2009 Nov; 24(15):2260-6. PubMed ID: 19845000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
    Thobois S; Ribeiro MJ; Lohmann E; Dürr A; Pollak P; Rascol O; Guillouet S; Chapoy E; Costes N; Agid Y; Remy P; Brice A; Broussolle E;
    Arch Neurol; 2003 May; 60(5):713-8. PubMed ID: 12756135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene.
    Hilker R; Klein C; Ghaemi M; Kis B; Strotmann T; Ozelius LJ; Lenz O; Vieregge P; Herholz K; Heiss WD; Pramstaller PP
    Ann Neurol; 2001 Mar; 49(3):367-76. PubMed ID: 11261512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism.
    Scherfler C; Khan NL; Pavese N; Eunson L; Graham E; Lees AJ; Quinn NP; Wood NW; Brooks DJ; Piccini PP
    Brain; 2004 Jun; 127(Pt 6):1332-42. PubMed ID: 15090472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans.
    Hilker R; Klein C; Hedrich K; Ozelius LJ; Vieregge P; Herholz K; Pramstaller PP; Heiss WD
    Neurosci Lett; 2002 Apr; 323(1):50-4. PubMed ID: 11911988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo assessment of brain monoamine systems in parkin gene carriers: a PET study.
    Pavese N; Moore RY; Scherfler C; Khan NL; Hotton G; Quinn NP; Bhatia KP; Wood NW; Brooks DJ; Lees AJ; Piccini P
    Exp Neurol; 2010 Mar; 222(1):120-4. PubMed ID: 20043906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigral degeneration and striatal dopaminergic dysfunction in idiopathic and Parkin-linked Parkinson's disease.
    Hu MT; Scherfler C; Khan NL; Hajnal JV; Lees AJ; Quinn N; Wood NW; Brooks DJ
    Mov Disord; 2006 Mar; 21(3):299-305. PubMed ID: 16211589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia.
    Binkofski F; Reetz K; Gaser C; Hilker R; Hagenah J; Hedrich K; van Eimeren T; Thiel A; Büchel C; Pramstaller PP; Siebner HR; Klein C
    Neurology; 2007 Aug; 69(9):842-50. PubMed ID: 17724286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
    Whone AL; Watts RL; Stoessl AJ; Davis M; Reske S; Nahmias C; Lang AE; Rascol O; Ribeiro MJ; Remy P; Poewe WH; Hauser RA; Brooks DJ;
    Ann Neurol; 2003 Jul; 54(1):93-101. PubMed ID: 12838524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations.
    Wu RM; Shan DE; Sun CM; Liu RS; Hwu WL; Tai CH; Hussey J; West A; Gwinn-Hardy K; Hardy J; Chen J; Farrer M; Lincoln S
    Mov Disord; 2002 Jul; 17(4):670-5. PubMed ID: 12210855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
    Burn DJ; Sawle GV; Brooks DJ
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):278-84. PubMed ID: 8158173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred.
    Sawle GV; Wroe SJ; Lees AJ; Brooks DJ; Frackowiak RS
    Ann Neurol; 1992 Nov; 32(5):609-17. PubMed ID: 1449241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
    Criswell SR; Perlmutter JS; Videen TO; Moerlein SM; Flores HP; Birke AM; Racette BA
    Neurology; 2011 Apr; 76(15):1296-301. PubMed ID: 21471467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations.
    Portman AT; Giladi N; Leenders KL; Maguire P; Veenma-van der Duin L; Swart J; Pruim J; Simon ES; Hassin-Baer S; Korczyn AD
    Neurology; 2001 Jun; 56(12):1759-62. PubMed ID: 11425950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation.
    Khan NL; Scherfler C; Graham E; Bhatia KP; Quinn N; Lees AJ; Brooks DJ; Wood NW; Piccini P
    Neurology; 2005 Jan; 64(1):134-6. PubMed ID: 15642918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations.
    Scherfler C; Khan NL; Pavese N; Lees AJ; Quinn NP; Brooks DJ; Piccini PP
    Mov Disord; 2006 Jun; 21(6):783-8. PubMed ID: 16511856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.
    Burn DJ; Brooks DJ
    Neurology; 1993 Mar; 43(3 Pt 1):552-6. PubMed ID: 8451000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles.
    Hagenah JM; König IR; Becker B; Hilker R; Kasten M; Hedrich K; Pramstaller PP; Klein C; Seidel G
    J Neurol; 2007 Oct; 254(10):1407-13. PubMed ID: 17934880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.